Precision Optics (POCI) Lytham Partners Fall 2024 Investor Conference summary

Business overview and strategy

• Focuses on micro-optics, 3D endoscopes, and digital imaging, primarily for medical devices, with growing defense aerospace programs.

• Vertically and horizontally integrated, offering design, fabrication, and full-system manufacturing.

• Business model centers on early customer engagement, retaining IP, and transitioning products from development to long-term production.

• Revenue model relies on a robust product development pipeline feeding into production, supporting sustained growth.

• Acquisitions, such as Lighthouse Imaging and Ross Optical, have expanded technical and component capabilities.

Financial performance and outlook

• Revenue has shown steady growth over the past seven to eight years, with a slight dip in the most recent year due to several customer program suspensions.

• Engineering and product development revenue continued to grow, offsetting some production losses.

• New programs transitioned from development to production, helping recover most lost revenue.

• Q4 and Q1 were weak due to ramp-up of new production, but significant revenue growth is expected in Q2 and a return to record levels by fiscal 2025.

• Product development pipeline remains at record levels, supporting future growth.

Technology and market focus

• Manufactures some of the world's smallest optical components, enabling advanced minimally invasive medical procedures.

• 3D endoscopes are a specialty, critical for robotic surgery, requiring high-precision manufacturing.

• Digital imaging capabilities enhanced by Lighthouse Imaging acquisition, allowing end-to-end system design and manufacturing.

• Long-standing products in spine and ENT applications demonstrate product longevity.

• Single-use endoscopes represent a fast-growing market, with a recent $9 million production order ramping up.